Skip to main content

Table 1 Values are presented as n or median (interquartile range)

From: Circulating concentrations of GLP-1 are associated with coronary atherosclerosis in humans

Characteristics n = 303
Age (yrs) 63 (55–70)
Sex  
  Male 202
  Female 101
Body mass index (kg/m 2 ) 26.2 (24.1-29.0)
Hypertension *  
  Yes 147
  No 126
Diabetes mellitus *  
  Yes 20
  No 253
Smoker  
  Yes 42
  No 230
Family history of CAD  
  Yes 77
  No 195
Laboratory profile  
  LDL-cholesterol (mg/dl) 122 (95–149)
  HDL-cholesterol (mg/dl) 52 (44–59)
  Triglycerides (mg/dl) 143 (106–207)
  High-sensitivity CRP (mg/dl) 0.23 (0.05-0.54)
  TNFa (pg/ml) 6,3 (4.5-7.9)
  eGFR (ml/min) 71 (63–80)
  IL6 (pg/ml) 0 (0–3.2)
  GLP-1 (pM) 2.9 (1.5-4.9)
Medical treatment  
  Statin 120
  Aspirin, Plavix or Marcumar 170
  Betablocker 173
  ACE-I or ARB 138
  Diuretics 87
  Insulin or OAD 16
CT data  
Pericardial adipose tissue volume (ml) § 190 (132–259)
Number of coronary artery plaques (total) || 3 (1–6) (range 0–26)
  Number of calcified plaques 1 (0–3) (range 0–22)
  Number of mixed plaques 0 (0–1) (range 0–10)
  1. *History of diabetes and hypertension is known in 273 patients.
  2. History of smoking and family history of CAD is known in 272 patients.
  3. Medication is known in 258 patients.
  4. §Adequate image quality for evaluation of PAT volume was obtained in 287 patients.
  5. ||Adequate image quality for evaluation of coronary plaques was obtained in 281 patients.